Sir,
A recent publication on surgical site infection and malignant soft tissue tumors is very interesting. Morii et al. [1] concluded, “Surgical site infections remain a critical and frequent complication of surgical treatment of soft-tissue malignancies and often result in prolongation of hospital stay.” Indeed, wound care seems to be an important factor for controlling wound infection. Any infection might imply poor infection control by the hospital. The reported incidence of 7 % is considerably high, but does not vary greatly from that reported for general orthopedics patients [2]. A good continuous infection control program should be established in order to control the problem. Re-evaluation and revision of the program for continuous quality improvement are suggested [3].
References
Morii T, Mochizuki K, Tajima T, Ichimura S, Satomi K. Surgical site infection in malignant soft tissue tumors. J Orthop Sci. 2011 (Epub ahead of print).
Jeon IH, Morrey BF, Anakwenze OA, Tran NV. Incidence and implications of early postoperative wound complications after total elbow arthroplasty. J Shoulder Elbow Surg. 2011;20:857–65.
Hawn MT, Vick CC, Richman J, Holman W, Deierhoi RJ, Graham LA, Henderson WG, Itani KM. Surgical site infection prevention: time to move beyond the surgical care improvement program. Ann Surg. 2011;254:494–9.
Author information
Authors and Affiliations
Corresponding author
Additional information
An answer to this letter to the editor is available at doi:10.1007/s00776-012-0211-2.
About this article
Cite this article
Wiwanitkit, V. Surgical site infection and malignant soft tissue tumors. J Orthop Sci 17, 336 (2012). https://doi.org/10.1007/s00776-012-0210-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00776-012-0210-3